{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:02:52Z","timestamp":1788984172211,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008725","name":"Agencia Nacional de Investigaci\u00f3n e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006049","name":"Comisi\u00f3n Sectorial de Investigaci\u00f3n Cient\u00edfica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jid.2021.08.442","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T16:55:42Z","timestamp":1634316942000},"page":"1435-1443.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Preclinical Evaluation of LVR01 Attenuated Salmonella as Neoadjuvant Intralesional Therapy in Combination with Chemotherapy for Melanoma Treatment"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2052-4114","authenticated-orcid":false,"given":"Sof\u00eda","family":"Chilibroste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6006-0713","authenticated-orcid":false,"given":"Amy","family":"M\u00f3naco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7751-4876","authenticated-orcid":false,"given":"Mar\u00eda C.","family":"Plata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6542-7599","authenticated-orcid":false,"given":"Magdalena","family":"Vola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6425-3520","authenticated-orcid":false,"given":"Caroline I.","family":"Agorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1759-228X","authenticated-orcid":false,"given":"Jos\u00e9 A.","family":"Chabalgoity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7294-6693","authenticated-orcid":false,"given":"Mar\u00eda","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2021.08.442_bib1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/jgm.1023","article-title":"Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma","volume":"9","author":"Agorio","year":"2007","journal-title":"J\u00a0Gene Med"},{"key":"10.1016\/j.jid.2021.08.442_bib2","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene laherparepvec improves durable response rate in patients with advanced melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2021.08.442_bib3","unstructured":"Babjuk M, Burger M, Comp\u00e9rat E, Gontero P, Mostafid AH, Palou J, et\u00a0al. EUA guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS) [EAU guidelines]. Edn. Paper presented at: EAU Annual Congress. 17\u201321 July 2020; Amsterdam, The Netherlands."},{"key":"10.1016\/j.jid.2021.08.442_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fimmu.2018.00007","article-title":"Salmonella immunotherapy improves the outcome of CHOP chemotherapy in non-Hodgkin lymphoma-bearing mice","volume":"9","author":"Bascuas","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2021.08.442_bib5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0264-410X(00)00197-3","article-title":"Salmonella typhimurium as a basis for a live oral Echinococcus granulosus vaccine","volume":"19","author":"Chabalgoity","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jid.2021.08.442_bib6","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.08.442_bib7","first-page":"1594","volume":"12","author":"Cunningham","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jid.2021.08.442_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40425-018-0381-3","article-title":"White paper on microbial anti-cancer therapy and prevention","volume":"6","author":"Forbes","year":"2018","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.jid.2021.08.442_bib9","doi-asserted-by":"crossref","first-page":"e00149","DOI":"10.1002\/prp2.149","article-title":"Analysis of drug combinations: current methodological landscape [published correction appears in Pharmacol Res Perspect 2019;7:e00549]","volume":"3","author":"Foucquier","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jid.2021.08.442_bib10","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00262-013-1449-z","article-title":"Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion","volume":"62","author":"Fritzell","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jid.2021.08.442_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/exd.13417","article-title":"Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages","volume":"27","author":"Fujimura","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2021.08.442_bib12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/imm.12320","article-title":"Salmonella enterica serovar typhimurium immunotherapy for B-cell lymphoma induces broad anti-tumour immunity with therapeutic effect","volume":"143","author":"Grille","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.jid.2021.08.442_bib13","first-page":"2984247","article-title":"Cancer immunotherapy: priming the host immune response with live attenuated Salmonella enterica","volume":"2018","author":"Hern\u00e1ndez-Luna","year":"2018","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.jid.2021.08.442_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/jid.2012.273","article-title":"Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth","volume":"133","author":"Hervieu","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.08.442_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma [published correction appears in N Engl J Med 2010;363:1290]","volume":"363","author":"Hodi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.08.442_bib16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/291238a0","article-title":"Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines","volume":"291","author":"Hoiseth","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.jid.2021.08.442_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jid.2020.03.943","article-title":"Treatment of advanced melanoma in 2020 and beyond","volume":"141","author":"Jenkins","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.08.442_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2010.12.004","article-title":"PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in\u00a0vitro and in\u00a0vivo","volume":"654","author":"Jin","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jid.2021.08.442_bib20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/s12885-015-1618-x","article-title":"Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice","volume":"15","author":"Kramer","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jid.2021.08.442_bib22","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1038\/jid.2008.59","article-title":"Topical CpG enhances the response of murine malignant melanoma to dacarbazine","volume":"128","author":"Najar","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.08.442_bib23","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(14)60958-2","article-title":"Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial","volume":"384","author":"Robert","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2021.08.442_bib24","first-page":"21","article-title":"Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview","volume":"19","author":"Serrone","year":"2000","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.jid.2021.08.442_bib25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.mayocp.2014.02.002","article-title":"Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma","volume":"89","author":"Shah","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jid.2021.08.442_bib26","doi-asserted-by":"crossref","first-page":"MMT27","DOI":"10.2217\/mmt-2019-0007","article-title":"The emergence of neoadjuvant therapy in advanced melanoma","volume":"6","author":"Sun","year":"2019","journal-title":"Melanoma Manag"},{"key":"10.1016\/j.jid.2021.08.442_bib27","doi-asserted-by":"crossref","DOI":"10.4161\/2162402X.2014.978709","article-title":"Tumor stroma and chemokines control T-cell migration into melanoma following temozolomide treatment","volume":"4","author":"Tan","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jid.2021.08.442_bib28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","article-title":"Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma","volume":"20","author":"Toso","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2021.08.442_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/jid.2012.341","article-title":"Dacarbazine in melanoma: from a chemotherapeutic drug to an immunomodulating agent","volume":"133","author":"Ugurel","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.08.442_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2217\/imt-2017-0188","article-title":"TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy","volume":"10","author":"Vola","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jid.2021.08.442_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-3-319-22539-5_8","article-title":"Chemotherapy for melanoma","volume":"167","author":"Wilson","year":"2016","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.jid.2021.08.442_bib32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.cmr.0000232294.14408.6a","article-title":"Alkylating benzamides with melanoma cytotoxicity: experimental chemotherapy in a mouse melanoma model","volume":"16","author":"Wolf","year":"2006","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jid.2021.08.442_bib33","first-page":"3918","article-title":"An obligatory anaerobic Salmonella typhimurium strain redirects M2 macrophages to the M1 phenotype","volume":"15","author":"Yang","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jid.2021.08.442_bib34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat Rev Cancer"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21023174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21023174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:49:59Z","timestamp":1762206599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X21023174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0022202X21023174"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2021.08.442","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical Evaluation of LVR01 Attenuated Salmonella as Neoadjuvant Intralesional Therapy in Combination with Chemotherapy for Melanoma Treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2021.08.442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}